 increased costs ($33,629). By contrast, VLU
treated with surgical intervention of the superﬁcial venous
system did not signiﬁcantly increase total cost over that of
patients receiving best medical therapy ($11,960 vs
$12,304) but signiﬁcantly reduced recurrence rates (34%
vs 5%). By, contrast, patients treated for outﬂow obstruction had a twofold increase